Patents Assigned to FORMYCON AG
  • ACE2 FUSION PROTEINS AND USES THEREOF
    Publication number: 20250082737
    Abstract: The present invention relates to fusion proteins of ACE2 with IgM or IgG2 Fc and the medical use of these fusion proteins, in particular in the prevention or treatment of infections with coronaviruses such as SARS-CoV-2.
    Type: Application
    Filed: July 29, 2022
    Publication date: March 13, 2025
    Applicant: Formycon AG
    Inventors: Johann Sebastian BUCHNER, Hristo Lyubomirov SVILENOV
  • IMPROVED ACE2 FUSION PROTEINS
    Publication number: 20250027067
    Abstract: The present invention relates to fusion proteins of ACE2 with IgG Fc and the medical use of these fusion proteins, in particular in the prevention or treatment of infections with coronaviruses such as SARS-CoV-2, as well as methods of producing them.
    Type: Application
    Filed: November 24, 2022
    Publication date: January 23, 2025
    Applicant: Formycon AG
    Inventors: Alwin REITER, Carsten BROCKMEYER, Florian WOLSCHIN
  • FORMULATIONS OF ANTI-PD1 ANTIBODIES
    Publication number: 20240287185
    Abstract: The present invention relates to pharmaceutical compositions of an anti-PD1 antibody comprising acitrate buffer, one or more amino acids other than histidine and a surfactant.
    Type: Application
    Filed: June 22, 2022
    Publication date: August 29, 2024
    Applicant: Formycon AG
    Inventors: Rainer Sigl, Katharina Maria Schott
  • FORMULATIONS OF ACE2 FC FUSION PROTEINS
    Publication number: 20240139296
    Abstract: The present invention relates to pharmaceutical compositions of ACE2 Fc fusion proteins and therapeutic uses thereof, in particular in the treatment of infections with SARS-CoV-2.
    Type: Application
    Filed: March 3, 2022
    Publication date: May 2, 2024
    Applicant: Formycon AG
    Inventors: Alwin REITER, Rainer SIGL
  • Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist
    Patent number: 11666632
    Abstract: A pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist, for example Ranibizumab, in a pre-filled pharmaceutical package, for example a syringe, cartridge, or vial, made in part or in whole of a thermoplastic polymer, coated on the interior with a tie coating or layer, a barrier coating or layer, a pH protective coating or layer, and optionally a lubricity coating or layer. Stability performance of the VEGF-antagonist packaged in the coated COP vessel comparable to or better than glass was obtained.
    Type: Grant
    Filed: February 26, 2022
    Date of Patent: June 6, 2023
    Assignees: FORMYCON AG, SIO2 MEDICAL PRODUCTS, INC., KLINGE BIOPHARMA GMBH
    Inventors: Carsten Brockmeyer, Christopher Weikart, Murray Stephen Bennett, Jean-Pierre Giraud, Thomas Strungmann
  • PRE-FILLED PLASTIC SYRINGE CONTAINING A VEGF ANTAGONIST
    Publication number: 20220362441
    Abstract: The present invention relates to a pre-filled syringe containing a VEGF antagonist and comprising a plastic barrel which is silicone-free, kits comprising this syringe and the use of the syringe for the administration of a VEGF antagonist in the treatment of ocular diseases.
    Type: Application
    Filed: July 18, 2022
    Publication date: November 17, 2022
    Applicant: FORMYCON AG
    Inventor: Bernd FIEDLER
  • Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist
    Patent number: 11298405
    Abstract: A pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist, for example Ranibizumab, in a pre-filled pharmaceutical package, for example a syringe, cartridge, or vial, made in part or in whole of a thermoplastic polymer, coated on the interior with a tie coating or layer, a barrier coating or layer, a pH protective coating or layer, and optionally a lubricity coating or layer. Stability performance of the VEGF-antagonist packaged in the coated COP vessel comparable to or better than glass was obtained.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: April 12, 2022
    Assignees: FORMYCON AG, SIO2 MEDICAL PRODUCTS, INC., KLINGE BIOPHARMA GMBH
    Inventors: Carsten Brockmeyer, Christopher Weikart, Murray Stephen Bennett, Jean-Pierre Giraud, Thomas Strungmann
  • Liquid formulation of a VEGF antagonist
    Patent number: 10576128
    Abstract: The present invention relates to liquid pharmaceutical compositions of a VEGF antagonist for intravitreal administration comprising a histidine buffer, an inorganic salt, a carbohydrate and a polysorbate.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: March 3, 2020
    Assignee: FORMYCON AG
    Inventor: Rainer Sigl
  • Pharmaceutical composition of an anti-VEGF antibody
    Patent number: 10568951
    Abstract: The present invention relates to liquid pharmaceutical formulations for intravitreal injection of an anti-VEGF antibody which does not contain saccharides for use in the treatment of age-related macular degeneration.
    Type: Grant
    Filed: November 13, 2014
    Date of Patent: February 25, 2020
    Assignee: FORMYCON AG
    Inventor: Rainer Sigl
  • Liquid Formulation of a VEGF Antagonist
    Publication number: 20190030123
    Abstract: The present invention relates to liquid pharmaceutical compositions of a VEGF antagonist for intravitreal administration comprising a histidine buffer, an inorganic salt, a carbohydrate and a polysorbate.
    Type: Application
    Filed: January 26, 2017
    Publication date: January 31, 2019
    Applicant: FORMYCON AG
    Inventor: Rainer SIGL
  • PRE-FILLED PLASTIC SYRINGE CONTAINING A VEGF ANTAGONIST
    Publication number: 20180326126
    Abstract: The present invention relates to a pre-filled syringe containing a VEGF antagonist and comprising a plastic barrel which is silicone-free, kits comprising this syringe and the use of the syringe for the administration of a VEGF antagonist in the treatment of ocular diseases.
    Type: Application
    Filed: November 18, 2016
    Publication date: November 15, 2018
    Applicant: FORMYCON AG
    Inventor: Bernd FIEDLER